Description
PATIENT PERSCRIPTION DRUG TREPROSTINIL
First action · last action
2015-02-27 · 2015-06-12
Transactions
2
First transaction's obligation
$6,033
Base + all options value (sum of deltas)
$5,853
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40275
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-02-27+$6,033= $6,033
- Mod P000012015-06-12-$180= $5,853
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-02-27 | +$6,033 | $6,033 | PATIENT PERSCRIPTION DRUG TREPROSTINIL |
| Mod P00001· CLOSE OUT | 2015-06-12 | −$180 | $5,853 | PATIENT PERSCRIPTION DRUG TREPROSTINIL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KK5FBFA43JS7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0777 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $33,158 | FY2026 |
| 36C24526N0755 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
| 36C24526N0754 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $15,746 | FY2026 |
| 36C24526N0723 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
| 36C24526N0722 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
| 36C24526N0707 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
Other recipients under 6505 from 509-AUGUSTA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24716F1159 | CSL BEHRING L.L.C. | 509-AUGUSTA | $6,354 | FY2016 |
| VA24715J1784 | PFIZER INC | 509-AUGUSTA | $6,785 | FY2015 |
| VA24715J1662 | VANDA PHARMACEUTICALS INC. | 509-AUGUSTA | $5,242 | FY2015 |
| VA24715J1325 | PFIZER INC | 509-AUGUSTA | $6,785 | FY2015 |
| VA24714P3476 | CAREMARK, L.L.C. | 509-AUGUSTA | $5,435 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24715F1228_3600_V797D40275_3600 · retrieved 2026-09-26.